UK SMA Patient Registry

Abroad (travel likely)Recruiting

Conditions

Spinal Muscular Atrophy · SMA

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

John Walton Muscular Dystrophy Research Centre, Newcastle upon Tyne, United Kingdom
Contact: Study coordinator (Patient Registry manager and curator) · smaregistry@newcastle.ac.uk · 0191 2418640
Contact: Study coordinator (Patient Registry Team) · registries@newcastle.ac.uk
Contact: Principal Investigator (Chiara Marini-Bettolo, MD, PhD)

Study leads

Chiara Marini-Bettolo, MD, PhD
Principal Investigator
Newcastle University

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of Intravenous Administration of ARGX-119 in Pediatric Participants Aged 5 to Less Than 18 Years With Spinal Muscular Atrophy

Spinal Muscular Atrophy (SMA)

Abroad (travel likely)RecruitingPHASE2

Little Rock, United States · San Diego, United States

VRehab-SMA Phase 1.2

Spinal Muscular Atrophy (SMA)

Abroad (travel likely)Recruiting

Oxford, United Kingdom

Assessment of a Portable Digital Device for Quantified Analysis of Markerless Walking in Volunteers With Neuromuscular Diseases or Asymptomatic Volunteers

Spinal Muscular Atrophy (SMA) · Charcot-Marie-Tooth · Muscular Dystrophy

Abroad (travel likely)Recruiting

Paris, France

Invasive Home Ventilation in Denmark

Neuromuscular Diseases (NMD) · ALS (Amyotrophic Lateral Sclerosis) · Spinal Cord Injuries (SCI)

Abroad (travel likely)Recruiting

Copenhagen, Denmark